An observational post-authorization safety study to describe the safety of ustekinumab and other treatments of ulcerative colitis in a cohort of patients with ulcerative colitis using the French Nationwide claims database (SNDS) France First published 02/07/2020 Last updated 26/11/2025 EU PAS number:EUPAS36129 Study Ongoing